Recent Finacing
Recent Raise
Prestwick Pharmaceuticals acquires abandoned drug candidates and advances them into neuro-focused therapeutics, sourcing external assets to build a portfolio of treatments for neurological disorders from Washington, D.C.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
